Summary Serum-free media conditioned by the androgen insensitive human prostate cancer cell line DU145 showed immunological transforming growth factor-a (TGFa) activity, as well as competing activity in epidermal growth factor (EGF) radioreceptor assays (RRA). Furthermore, there were factors in the conditioned media which inhibited and stimulated DNA synthesis by DU145 
The secretion of growth factors by some transformed cells is thought to enable these cells to proliferate in low serum concentrations as well as reducing the dependency upon exogenous growth factors. One mechanism of transformation is thought to involve cells being able to produce and respond to growth factors (autocrine secretion), thus conferring a growth advantage over other cells (Sporn & Todaro, 1980) .
Transforming growth factors (TGFs) and other growth factors have been implicated in the autocrine and/or paracrine growth of tumour cells (Spom & Roberts, 1985) . A lot of interest has arisen in TGFs, as they are a family of peptides which confer upon non-transformed cells several properties associated with the transformed phenotype, such as anchorage-independent growth in semisolid medium (Brown & Blakely, 1984) . TGFs are also unique in that their expression is elevated in transformed cells (Marquardt et al., 1983) .
One class of TGFs is the TGFas. They are potent mitogens for a number of cell types and bind to and interact with the epidermal growth factor (EGF) receptor (Massague, 1983) . TGFas have significant sequence and structural homology to EGF and show a variety of biological actions similar to EGF. Their biological activities when assayed in cell culture systems are almost identical (Bascom et al., 1989) , although in some cases TGFs are more potent than EGF (Stern et al., 1985; Ibbotson et al., 1986) .
TGFas have been identified and purified from various sources. Biologically active TGFaxs have been demonstrated in crude or partially purified extracts prepared from rodent and human mammary tumours and in the conditioned medium (CM) obtained from several human cell lines (Zwiebel et al., 1982; Brown & Blakely, 1984; Moses, 1984; Salomon et al., 1984 Salomon et al., , 1986 Dickson et al., 1986; Perroteau et al., 1986) . In addition TGFa has been shown to be produced by the hormone responsive LNCaP prostate cell line (Wilding et al., 1989 (Stone et al., 1978) EGF radioreceptor assay Binding assays were carried out on DU145 monolayers, in 24-well plates (Cell-Cult) at a cell density of 2 x 105 cells per well. Before addition of the binding medium, the SFM from each well was aspirated and the cells and binding media were cooled on ice to inhibit receptor internalisation. The cell monolayers were then gently washed with Dulbecco 'A' PBS and binding was initiated upon the addition of the appropriate concentration of '25I-EGF (Amersham; specific activity 4 GBq pg'), in 0.5ml of 0.02moll1' PBS (0.02mol Na2 HPO4.2H20 1-', 0.02 mol NaH2PO4.2H20 1-', 0.9% NaCl, I g 1-' BSA) pH 7.4. Non-specific binding was determined in the presence of 100-fold excess unlabelled EGF or CM in RPMI 1640. All binding studies were carried out for 3 h at 4°C. Unbound '251-EGF was separated from cell bound 1251_ EGF by washing the cells 3 x in Dulbecco 'A' PBS. The cells were subsequently solubilised with 1 ml 0.5 N NaOH, for 15 min and transferred to plastic tubes for counting in a gamma counter. Specfic binding was calculated as the difference between total binding and non-specific binding. Cell numbers were determined from control wells (triplicate wells) in which RPMI 1640 was added, without EGF.
Saturation and competition analysis Evaluation of binding parameters were obtained by saturation analysis over the range 0.05-8 nmolI" 1 25I-EGF with or without excess unlabelled EGF. The dissociation constant (Kd) and the number of binding sites (RT) were also measured by competition analysis with increasing concentrations of EGF (0.01-200 nmol 1') and a constant amount of 12511 EGF (2 nmol 1-').
Radioreceptor competition assay (RRA) DU145 cell monolayers were used as the source of EGF receptors in the EGF-RRA, for analysis of competitive activity in the CM. The amount of EGF equivalent units in samples of CM was calculated by comparison with the competition curves derived from unlabelled hEGF, with '25I-EGF competing for EGF binding sites on DU145 cells. In this assay the sensitivity for unlabelled mEGF, hEGF or TGFa is approximately 0.12 ng per assay with 1 ng of 251I-EGF and 50% competition occurring at 0.6 ng per assay.
Reverse-phase high performance liquid chromatography The lyophilisate of CM stored at -70°C was reconstituted in 5 ml of PBS. Trifluro acetic acid (TFA; 0.1%) was added to an aliquot (10 mg) of the CM, vortexed and spun at 15,000 r.p.m. for 10 min. The soluble material was loaded on to a Bio-Rad RP 304 C4 column (250 mm x 10 mm), with a slurry packed guard column of the same material. The column was equilibrated with 95% Buffer A (0.21tm filtered double distilled water (ddw), 0.1% TFA) and 5% Buffer B (20% ddw, 80% acetonitrile (MeCN), 0.085% TFA), and the sample eluted with a linear gradient of 5-80% Buffer B, with a flow rate of 0.5 ml min-' at 22°C. The absorbence of each fraction was read at 280 nm with 1 ml fractions collected. Acetonitrile was blown off each fraction under a stream of air, over 24 h, and the remaining sample frozen to -70°C, lyophilised to dryness and reconstituted in 0.5 ml of 0.02 M PBS with 1 g 1' BSA, pH 7.4. Every third fraction was analysed for competitive activity in an EGF-RRA as previously described and for hEGF and rTGF-I immunological activity by RIA.
Radioimmunoassays for TGFac and hEGF
The amount of immunoreactive TGFa and hEGF in samples of CM and in the rHPLC fractions were determined using a liquid-phase competitive RIA. Detection of TGFa was performed using a commerical kit (Peninsula Laboratories Inc.) with rTGF I as radioiodinated tracer and reference standard. Antisera to the rTGF I were raised in rabbits and purchased from Peninsula Laboratories Europe Ltd. The rabbit anti-rat TGF I antiserum recognises both mouse and human TGFa but does not cross react with either mouse or human EGF.
Half-maximal inhibition of binding of the 251I-peptide to the antibody occurred at 100 pg per tube. EGF-life activity was determined from the competition of hEGF for '251I-EGF binding to anti hEGF serum. Briefly antiserum raised in rabbits to purified hEGF (kindly provided by Dr H. Gregory, ICI Macclesfield, UK) was incubated at 4°C with 1251I-EGF (10,000 c.p.m. per assay tube) and hEGF standards (0-20 ng in triplicate) or CM samples. After 3 days donkey anti-rabbit polyclonal IgG (Scottish Antibody Production Unit, Carluke, UK) was added for 24 h at 4°C. The assay tubes were then centrifuged at 3,000 r.p.m. for 30 min. The supernatant was aspirated and the resultant radiolabel in the pellets was determined by counting in a gamma counter. Half-maximal competition was observed with 1-2 ng native hEGF.
Data analysis
The computer analysis employed for competition and saturation analysis was the weighted, non-linear least-squares curve fitting program LIGAND (DeLean et al., 1978; Munson & Rodbard, 1980) . Data were analysed according to a model for one or two binding sites. A model for two binding sites is retained only when it fits the data significantly better (P<0.05 partial F test) than a model for a single binding site.
Statistical significance in the growth experiments was determined using a two-tailed Student's t test for comparison of means.
Results

Production of EGF-like competing factors
To examine for the presence of specific EGF-like molecules in the conditioned media from DU145 cells, increasing concentrations of CM were tested for their ability to compete with '25I-EGF for binding to DUI45 cells (Figure 1) . Growth factors present in the CM inhibited '251-EGF in a dose Figure  2 . Factors in the conditioned media had a biphasic effect on DNA synthesis, with concentrations from 0.01 to ;Lg ml-' increased by 46 ± 28% (P 0.05) relative to the SFM control. The marked decline in 3H-thymidine incorporation with higher concentrations of CM was possibly due to dilution of nutrients in the media.
rHPLC profile of conditioned media Media conditioned by DU145 cells was chromatographed using rHPLC and the fractions examined for immunological rTGF 1, hEGF activity and EGF radioreceptor competitive activity (Figure 3) . Associated with the three major 280 nm absorbence peaks (1 Au) in the middle of the gradient was a minor peak of EGF radioreceptor competitive activity (20% Trifluroacetic acid (0.1 %) was added to concentrated CM (10mg). The soluble material was loaded on to a Bio-rad RP 304C4 column (250 mm x 1O mm) and subjected to rHPLC; 200 pi aliquots of every third fraction was assayed for competitive activity in an EGF RRA (-0 -), and 100 LI aliquots assayed for immunological hEGF and rTGF-1 activity by RIA (- competition). There were also two other major peaks of competitive activity eluted at the beginning and end of the run (40-50% competition). The only peak of immunoreactive rTGF I (fractions 12-19), which eluted with 25-35% acetonitrile also demonstrated EGF-like competitive activity (40% competition). All the fractions were tested for immunoreactive hEGF, but hEGF was not detected in any of the rHPLC fractions.
The effect of exogenous EGF and TGFcx on DNA synthesis The effect of exogenous EGF and TGFoa on DNA synthesis was measured by the incorporation of radiolabelled thymidine (Figure 4 ). Preliminary studies were carried out to examine the effect of EGF on DNA synthesis over a period of up to 72 h. Maximum stimulation was achieved after 24 h (data not shown) and subsequently all experiments were therefore performed after 24 h. Both EGF and TGFx stimulated 3H-thymidine incorporation into DU145 cells in a dosedependent manner. In the presence of 1 mmol EGF 1-' thymidine incorporation was increased by 26 ± 13% (P < 0.001) whereas TGFa maximally stimulated thymidine incorporation at a concentration of 0.03 nmol 1-I by 17 ± 10% (P <0.05). Similar results were obtained using cell numbers as an index of proliferation (data not shown).
Saturation and competition studies EGF receptor binding parameters (Kd and Bmax) were estimated by competition and saturation analysis ( Figure 5 ). Competition studies were carried out with increasing concentrations of unlabelled EGF and a constant amount of labelled ligand (2 nmol 1-'). Unlabelled EGF effectively competed for '25I-EGF binding, with a dissociation constant (Kd) of 0.6 ± 0.5 nmol 1'. The results fitted significantly to a one site receptor model as can be seen by the sigmoidal shape of the curve (P <0.05) icantly to a one class of binding site (P<0.05) with an estimated Kd value of 1 ± 0.5 nmol l-l and a Bmax of (2 + 0.8) x 105 per cell. Overall results from competition and saturation analysis using the LIGAND curve fitting program gave a Kd value of 1 ± 0.6 nmol l' with (2.5 ± 1.2) x 105 receptor binding sites per cell.
Binding parameters were evaluated only by competition and saturation analysis, due to the difficulty in estimating the lowest ligand concentrations, which are unevenly 'weighted' in Scatchard analysis (Bennett & Yamamura, 1985) .
Discussion
The results of this study demonstrate that the human prostatic cancer cell line DU145 produces molecules with TGFalike immunoreactivity and competitive activity in EGF radioreceptor assays; this suggests that this cell line may be involved in a TGFa-mediated autocrine loop. This is further substantiated by the presence of high affinity receptors for EGF on the cell surface. The DU145 cells in our experiments also responded to exogenous EGF and TGFa by showing an increase in 3H-thymidine in corporation. However, this response was minimal which suggests that these cells may be producing sufficient quantities of endogenous TGFas such that they are generally insensitive to proliferation by exogenous growth factors. The presence or lack of minimal proliferative response to exogenous growth factors has also been observed with other cell lines producing TGFas (Salomon et at., 1987; Verbeck et at., 1988; of receptors does not necessarily mean that a cell responds to a factor. In fact the loss of an EGF requirement after malignant transformation is well described (Cherington et al., 1979) . Wollenberg et al. (1989) noted that rat hepatocytes expressed receptors for EGF but that the high affinity receptors were not involved in the proliferative response. Media conditioned by DU145 cells had a significant stimulatory and inhibitory effect on DNA synthesis, which was dose responsive. Although other workers had examined the relationship between immortal human prostate cell lines and exogenous growth factors (Connolly & Rose, 1989; Wilding et al., 1989) , this is the first that an effect by CM was reported in human prostate cancer cells. The biphasic effect canhot, at this stage, be attributed solely to growth factor production, nonetheless it is interesting to note that this cell line is endogenously producing stimulatory and inhibitory 'factors' which are influencing the growth of these cells and this warrants further investigation.
Using an immune-specific RIA, we demonstrated the presence of TGFa in medium conditioned by this cell line. However, stoichiometrically the level of immunologically related TGFa was not equivalent to the amount of EGF-like competitive activity which suggests that this cell line is producing forms of EGF related polypeptides distinct immunologically from TGFa and hEGF. This was further verified using a HPLC as we identified several molecular forms of EGF receptor binding polypeptides in medium conditioned by DU145 cells. Only one of three peaks demonstrated TGFx immunoreactivity and none were related to hEGF. It is interesting to note that many other types of cancer cells produce several molecular forms related to TGFa (Dickson et al., 1986; Stromberg et al., 1986; Salomon et al., 1987) . The TGFa related molecular species produced by the DU145 prostate cell line may comprise the precursor form of TGFx or intermediate forms; further studies are required to distinguish between these possibilities. Nevertheless, this raises the possibility that it may be possible for a cell to make subtle changes in response by producing different molecular forms of TGFa. We conclude, therefore, that DU145 by producing its own growth factors has little or no need for exogenous EGF and TGFa; the levels of growth factors produced may be auto-stimulatory, although this remains to be determined.
